- CA$1.81bn
- CA$1.93bn
- CA$647.95m
- 91
- 37
- 75
- 76
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 25.03 | ||
PEG Ratio (f) | 1.88 | ||
EPS Growth (f) | 15.36% | ||
Dividend Yield (f) | 1.09% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 4.47 | ||
Price to Tang. Book | 22.87 | ||
Price to Free Cashflow | 17.53 | ||
Price to Sales | 2.78 | ||
EV to EBITDA | 11.64 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 17.55% | ||
Return on Equity | 14.91% | ||
Operating Margin | 14.63% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 289.99 | 314.34 | 440.12 | 648.42 | 647.95 | 653.19 | 689.48 | 18.52% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -62.96 | +23.79 | +129.47 | -20.53 | -13.03 | +2.59 | +15.36 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Andlauer Healthcare Group Inc. is a Canada-based supply chain management company. The Company offers a robust platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. Its 3PL services include customized logistics, distribution and packaging solutions for healthcare manufacturers across Canada. Its specialized transportation services in Canada, including air freight forwarding, ground transportation, dedicated delivery and last-mile services, provide a one-stop shop for clients' healthcare transportation needs. It operates in two segments: Specialized Transportation and Healthcare Logistics. Through its complementary service offerings, available across a coast-to-coast distribution network, it strives to accommodate the full range of its clients' specialized supply chain needs. The Company also provides specialized ground transportation services, primarily to the healthcare sector, across the 48 contiguous U.S. states.
Directors
- Peter Jelley CHM (48)
- Michael Andlauer CEO (56)
- Peter Bromley CFO
- Stephen Barr CEX
- Bob Brogan CEX
- Reg Sheen CEX
- Ronalee Ambrose LED (51)
- Cameron Joyce DRC (64)
- Joseph Schlett DRC (65)
- Andrew Clark IND (45)
- Evelyn Sutherland IND (47)
- Thomas Wellner IND (56)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- November 12th, 2019
- Public Since
- December 11th, 2019
- No. of Employees
- 2,290
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange
- Shares in Issue
- 39,251,497

- Address
- 100 Vaughan Valley Blvd., Vaughan, L4H 3C5
- Web
- https://andlauerhealthcare.com/
- Phone
- +1 4167444900
- Auditors
- KPMG LLP
Upcoming Events for AND
Q4 2024 Andlauer Healthcare Group Inc Earnings Call
Q1 2025 Andlauer Healthcare Group Inc Earnings Release
Andlauer Healthcare Group Inc Annual Shareholders Meeting
Q2 2025 Andlauer Healthcare Group Inc Earnings Release
Similar to AND
Avant Brands
Toronto Stock Exchange
dentalcorp Holdings
Toronto Stock Exchange
Extendicare
Toronto Stock Exchange
Lifespeak
Toronto Stock Exchange
Medical Facilities
Toronto Stock Exchange
FAQ
As of Today at 18:15 UTC, shares in Andlauer Healthcare are trading at CA$46.06. This share price information is delayed by 15 minutes.
Shares in Andlauer Healthcare last closed at CA$46.06 and the price had moved by +15.58% over the past 365 days. In terms of relative price strength the Andlauer Healthcare share price has underperformed the Toronto Stock Exchange 300 Composite Index by -4.56% over the past year.
The overall consensus recommendation for Andlauer Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Andlauer Healthcare dividend yield is 0.87% based on the trailing twelve month period.
Last year, Andlauer Healthcare paid a total dividend of CA$0.40, and it currently has a trailing dividend yield of 0.87%. We do not have any data on when Andlauer Healthcare is to next pay dividends.
We do not have data on when Andlauer Healthcare is to next pay dividends. The historic dividend yield on Andlauer Healthcare shares is currently 0.87%.
To buy shares in Andlauer Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$46.06, shares in Andlauer Healthcare had a market capitalisation of CA$1.81bn.
Here are the trading details for Andlauer Healthcare:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: AND
Based on an overall assessment of its quality, value and momentum Andlauer Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Andlauer Healthcare is CA$48.00. That is 4.21% above the last closing price of CA$46.06.
Analysts covering Andlauer Healthcare currently have a consensus Earnings Per Share (EPS) forecast of CA$1.60 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Andlauer Healthcare. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -0.12%.
As of the last closing price of CA$46.06, shares in Andlauer Healthcare were trading +12.65% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Andlauer Healthcare PE ratio based on its reported earnings over the past 12 months is 25.03. The shares last closed at CA$46.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Andlauer Healthcare's management team is headed by:
- Peter Jelley - CHM
- Michael Andlauer - CEO
- Peter Bromley - CFO
- Stephen Barr - CEX
- Bob Brogan - CEX
- Reg Sheen - CEX
- Ronalee Ambrose - LED
- Cameron Joyce - DRC
- Joseph Schlett - DRC
- Andrew Clark - IND
- Evelyn Sutherland - IND
- Thomas Wellner - IND